Liver transplantation.

Area of Science:

• Hepatology
• Transplantation Medicine
• Immunology

Background:

• Organ allocation and distribution in liver transplantation were debated in 2000 without significant system changes.
• Live donor adult-to-adult liver transplantation emerged as a key topic, with initial reports indicating excellent outcomes for recipients and donors.
• Recurrent viral hepatitis, specifically hepatitis B (HBV) and hepatitis C (HCV), remained a significant concern after liver transplantation.

Purpose of the Study:

• To review the advancements and challenges in liver transplantation during the year 2000.
• To highlight the growing experience and outcomes of live donor adult-to-adult liver transplantation.
• To summarize research on the management and prevention of viral hepatitis recurrence post-liver transplantation.

Main Methods:

• Review of published literature and reported experiences in liver transplantation from the year 2000.
• Analysis of initial outcomes data for live donor adult-to-adult liver transplantation.
• Synthesis of findings from studies investigating viral hepatitis (HBV and HCV) recurrence and treatment post-transplant.

Main Results:

• Live donor adult-to-adult liver transplantation demonstrated excellent initial results for both donors and recipients.
• Combination therapy with hepatitis B immunoglobulin and lamivudine showed potential benefits for recurrent hepatitis B, though breakthrough replication was noted.
• Risk factors for recurrent hepatitis C, including cellular rejection and viral load, were identified. Early treatment with interferon and ribavirin showed limited, short-lived viral response and poor tolerance.

Conclusions:

• Live donor adult-to-adult liver transplantation is a promising procedure with excellent early outcomes, warranting further long-term safety and efficacy studies.
• Combination therapy offers hope for improved long-term graft survival in hepatitis B patients, but further research is needed.
• Effective prevention and treatment strategies for recurrent viral hepatitis remain a critical area for future research in liver transplantation.